Cardiovascular disease remains a leading cause of morbidity and mortality in adults despite recent scientific advancements. Although people are living longer lives, there may be an adverse impact on ...

Mayo Clinic researchers are studying why some Alzheimer's patients decline rapidly, aiming to find causes, biomarkers, and ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer's disease (early AD) wh ...

The European Commission has today communicated that it has granted BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai's application for Marketing Authorization of ...

In addition to development in nrSPMS per the HERCULES trial, there is an ongoing Phase III study to investigate the efficacy ...

The Breakthrough Prize Foundation today announced the winners of the 2025 Breakthrough Prizes, honoring scientists driving ...

KBRA assigns preliminary ratings to eight classes of Progress Residential 2025-SFR3 ... The aggregate BPO value of the underlying homes is $782.4 million, yielding an LTV of 99.5%.

A precision medicine workflow integrating proteomics and personalized xenograft models was developed and applied to an adolescent with progressive SETTLE tumor. Target identification combined with pre ...

A blood test developed to detect Alzheimer’s disease can also show how far the disease has progressed and tell if symptoms are due to Alzheimer’s or another cause, a study finds. The report ...

WILLIAMSBURG, Va. (WAVY) — Busch Gardens in Williamsburg just released photos of progress being made on the new Big Bad Wolf roller coaster. Workers recently were able to put the new trains on ...

Chairman Alan Raleigh said: " I am pleased to report strong progress in 2024. Our results build on the positive momentum experienced in the second half of 2023. "We expect underlying operating ...

It can affect any part of the body when you have Huntington’s disease. Symptoms of Huntington’s disease progress over time, often leading to disability within a few years after the onset of symptoms.